Lipid mediator class switching during acute inflammation: signals in resolution

[1]  R. Bolli,et al.  Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  B. Levy,et al.  Oxidoreductases in Lipoxin A4 Metabolic Inactivation , 2000, The Journal of Biological Chemistry.

[3]  S. Swan,et al.  Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt Diet , 2000, Annals of Internal Medicine.

[4]  C. Clish,et al.  Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. , 2000, Biochemistry.

[5]  Hugh R. Brady,et al.  Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages1 , 2000, The Journal of Immunology.

[6]  C. Serhan,et al.  Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1 , 2000, The Journal of Immunology.

[7]  C. Clish,et al.  Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Y. Kaneda,et al.  Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Freeman,et al.  Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. , 1999, The Journal of clinical investigation.

[10]  D. Gilroy,et al.  Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.

[11]  B. Thiele,et al.  Tissue-specific translational regulation of alternative rabbit 15-lipoxygenase mRNAs differing in their 3'-untranslated regions. , 1999, Nucleic acids research.

[12]  Caroline Gilbert,et al.  Expression and activity of prostaglandin endoperoxide synthase‐2 in agonist‐activated human neutrophils , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  H. Herschman Recent progress in the cellular and molecular biology of prostaglandin synthesis. , 1998, Trends in cardiovascular medicine.

[14]  S. Feinmark,et al.  Is there a role for 15-lipoxygenase in atherogenesis? , 1997, Biochemical pharmacology.

[15]  J. Mancini,et al.  Suppression of Leukotriene B4 Biosynthesis by Endogenous Adenosine in Ligand-activated Human Neutrophils , 1997, The Journal of experimental medicine.

[16]  S. McColl,et al.  Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. , 1997, Journal of immunology.

[17]  Y. Mori,et al.  The co-culture of dermal fibroblasts with human epidermal keratinocytes induces increased prostaglandin E2 production and cyclooxygenase 2 activity in fibroblasts. , 1997, The Journal of investigative dermatology.

[18]  A. Ziober,et al.  Characterization and sequence of an additional 15-lipoxygenase transcript and of the human gene. , 1997, Biochimica et biophysica acta.

[19]  M. Cassatella,et al.  Activation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils , 1997 .

[20]  W. Boyar,et al.  Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2. , 1997, Biochemistry.

[21]  S. McColl,et al.  Involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-α , 1997 .

[22]  J. Cornhill,et al.  Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. , 1996, The Journal of clinical investigation.

[23]  T. Mayadas,et al.  Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. , 1996, Kidney international.

[24]  J. Bousquet,et al.  5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors , 1996, The Journal of experimental medicine.

[25]  The Nobel Foundation , 1996, Current Biology.

[26]  I. Akritopoulou‐Zanze,et al.  Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.

[27]  J. Drazen,et al.  Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. , 1993, The Journal of clinical investigation.

[28]  G. Weissmann Prostaglandins as modulators rather than mediators of inflammation. , 1993, Journal of lipid mediators.

[29]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[30]  S. McColl,et al.  Nuclear signaling in human neutrophils. Stimulation of RNA synthesis is a response to a limited number of proinflammatory agonists. , 1992, The Journal of biological chemistry.

[31]  E. Borrelli,et al.  Signal transduction and gene control: the cAMP pathway. , 1992, Critical reviews in oncogenesis.

[32]  R. Light Pleural diseases. , 1992, Disease-a-month : DM.

[33]  B. Samuelsson,et al.  Purification of two forms of arachidonate 15-lipoxygenase from human leukocytes. , 1991, European journal of biochemistry.

[34]  C. Serhan,et al.  Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils , 1990, The Journal of experimental medicine.

[35]  P. Naccache,et al.  Biosynthesis and biological activity of leukotriene B4. , 1990, Clinical biochemistry.

[36]  S. Dahlén,et al.  Enhancement of acute allergic inflammation by indomethacin is reversed by prostaglandin E2: apparent correlation with in vivo modulation of mediator release. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Mcmillan Blood: Atlas and Sourcebook of Hematology , 1982 .

[38]  Nobelstiftelsen Les Prix Nobel : Nobel Prizes, presentations, biographies and lectures , 1982 .

[39]  J. Salmon,et al.  Arachidonic acid-15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes. , 1982, Methods in enzymology.

[40]  S. Jenkinson,et al.  Radioimmunoassay determinations of prostaglandin E in pleural effusions of varying causes. , 1982, The American review of respiratory disease.

[41]  J. H. Jandl,et al.  Blood, atlas and sourcebook of hematology , 1991 .

[42]  J. Salmon,et al.  Arachidonic acid 15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes. Partial purification and properties. , 1981, The Journal of biological chemistry.

[43]  J. Vane,et al.  Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation , 1973, Nature.